Clinical Applications for the RH Blood Group System
Program Date: 13 July 2023
Publication Date: 13 July 2023
Continuing Education Units: Hours: 0.5
Lecture Description:
In this lecture, Dr Denomme will discuss RHD Zygosity and introduce a clinical application for RH molecular testing in transfusion medicine. He will also provide insights on new recommendations for RHD genotyping in pregnancy.Lecture Objectives:
• Discuss the molecular rationale underlying the classification of weak and partial D types
• Identify one clinical application for RH molecular testing in transfusion medicine
• Summarize new recommendations for RHD genotyping in pregnancy
- Run Time: 36
Lecture Instructor Bio(s)
Gregory Denomme, PhD, FCSMLS(D)
Laboratory Director and Head of Research and Development
Grifols Laboratory Solutions
Sanarcos, TX, USA
Dr Denomme is a clinical and academic trained scientist. He obtained a doctorate in microbiology and immunology and completed postdoctoral fellowships in platelet immunology and in Pathology and Molecular Medicine. Past academic appointments in include Associate Professorship, Laboratory Medicine and Pathobiology at the University of Toronto, and Senior Investigator with Versiti’s Blood Research Institute in Milwaukee. Presently, Dr Denomme is the Laboratory Director and Head of Research and Development at Grifols Laboratory Solutions in San Marcos, Texas. His applied research integrates blood group genetics and immunohematology to the study of blood group antigen expression and its impact on immune-mediated hemolytic disorders.
Completed a Lecture?
FREQUENTLY ASKED QUESTIONS